The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  Protalix BioTherapeutics Inc (PLX)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
rated strong buy

Sep 12, 2009 02:07 AM GMT
Return Risk
+12.82% LOW
Associate

Yesterday, Protalix BioTherapeutics, Inc. ( PLX - Snapshot Report ) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to prGCD for the treatment of Gaucher disease, an enzyme disorder that can cause liver and neurological problems

PLX:  This call was made on 09/12/09 @ $7.36
Rating:   Positive   $7.36 (09/12/09)
Gain/Loss:   -13.72% in 990 days
Target:   $8.00 (+8.70%) in Three months


Comments (1)

Add Comment

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 415 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.36% 531
2 Gerald Greene 18.14 +36.28% 286
3 stockmarketfunding.com 17.66 +23.07% 83
4 akiralegrand 13.47 +13.37% 69
5 anup2104 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment
BIDU Baiducom Inc ADS
NVDA NVIDIA Corp
MO Altria Group Inc
YHOO Yahoo! Inc
XOM Exxon Mobil Corp
GOOG Google Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Protalix BioTherapeutics Inc (PLX)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by legan
Symbol SP Sentiment Rating Return Since
CHLN Positive -56.46% 03/25/10
GSK Negative -4.20% 12/08/09
AOB Positive -62.84% 11/15/09
FREE Positive -57.41% 10/22/09
MATK Positive n/a 10/11/09

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch